Although the frequency of hypoglycemia was generally low in clinical trials testing GLP-1 receptor agonists in combination with sulphonylurea (with or without metformin) or insulin, it was higher compared to placebo [67,68]. The gene discussed is INS; the disease is Hypoglycemia.